Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|March 5, 2021
Cardiac autonomic function in patients with early multiple sclerosisRichard Imrich, Miroslav Vlcek, Adela Penesova, et al.Journal of the American Heart Association|February 19, 2020
Thrombolysis in Stroke With Unknown Onset Based on Non-Contrast Computerized Tomography (TRUST CT)Marek Sykora, Lars Kellert, Patrik Michel, et al.Frontiers in Neurology|January 10, 2018
Aerobic-Strength Exercise Improves Metabolism and Clinical State in Parkinson's Disease PatientsPatrik Krumpolec, Silvia Vallova, Lucia Slobodova, et al.International Journal of Stroke : Official Journal of the International Stroke Society|September 15, 2012
Stroke care in Central Eastern Europe: current problems and call for actionLaura Lenti, Michael Brainin, Ekaterina Titianova, et al.International Journal of Molecular Sciences|September 13, 2025
Real-World Laboratory Analysis of Molecular Biomarkers in Multiple Sclerosis Centers in Central-Eastern European Countries Covering 107 Million InhabitantsAnett Járdánházy, Thomas Berger, Harald Hegen, et al.Multiple Sclerosis and Related Disorders|November 22, 2022
Real-world operation of multiple sclerosis centres in Central-Eastern European countries covering 107 million inhabitantsZsófia Kokas, Anett Járdánházy, Dániel Sandi, et al.CNS Neuroscience & Therapeutics|April 24, 2013
Recommendations for the use of prolonged-release fampridine in patients with multiple sclerosis (MS)Jana Lizrova Preiningerova, Ulf Baumhackl, Tunde Csepany, et al.Lancet (London, England)|September 5, 2022
Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trialAshkan Shoamanesh, Hardi Mundl, Eric E Smith, et al.European Stroke Journal|January 30, 2026
Rationale, design and baseline characteristics of participants in the OCEANIC-STROKE trial of FXIa inhibition for secondary stroke preventionMukul Sharma, Qiang Dong, Teruyuki Hirano, et al.The New England Journal of Medicine|April 15, 2026
Asundexian for Secondary Stroke PreventionMukul Sharma, Qiang Dong, Teruyuki Hirano, et al.Pageof 4